JSA advised Truemeds on its Series C fundraises led by Accel and Peak XV Partners

  • Deal
  • August 12, 2025

JSA advised Intellihealth Solutions Private Limited (d/b/a Truemeds) and its Founders on its Series C fundraises. The round’s first close was led by Accel, followed by a second close led by Peak XV Partners, with significant participation from existing investors WestBridge and InfoEdge Ventures.

Truemeds is a leading telehealth platform which includes providing generic and substitute medicines,and is focused on enabling greater affordability in healthcare access.

The JSA transaction team was Rishabh Gupta (Partner), Akshath Mithal (Principal Associate), Tanmayee Shriprasad Apte (Associate), and Saurabh Chatterji (Associate).